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Abstract
Rates and characteristics of intracerebral cavernous malformations (ICMs) after cranial radiation 
therapy (CRT) remain poorly understood. Herein we report on ICMs detected on follow+up 
imaging in pediatric cancer patients who received CRT at age ≤ 18 years from 1980 to 2009. 
Through chart reviews (n=362) and phone interviews (n=104) of a retrospective cohort we 
identified 10 patients with ICMs. The median latency time for detection of ICMs after CRT was 
12 years (range 1+24 years) at a median age of 21.4 years (IQR 15+28). The cumulative incidence 
was 3% (95% CI 1+8%) at 10 years post CRT and 14% (95% CI 7+26%) at 15 years. Three 
patients underwent surgical resection. Two surgical specimens were pathologically similar to 
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sporadically occurring ICMs; one was consistent with capillary telangiectasia. ICMs are common 
after CRT and can show a spectrum of histological features.
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Introduction
Intracerebral cavernous malformations (ICMs) are increasingly recognized as one of the 
long+term sequelae of cranial radiation therapy (CRT), especially in pediatric 
populations 1-5. While the majority of these ICMs are asymptomatic, symptomatic lesions 
can present with seizure, new headache, and focal neurologic deficits due to hemorrhagic 
stroke. Pathologically, ICMs are characterized by a circumscribed cluster of dilated vascular 
sinusoids lined by a single endothelial layer, with little to no intervening brain 
parenchyma 1-5. Intralesional or perilesional deposits, including thrombus, calcification, and 
cysts are common, and ICMs are often bordered by hemosiderin and reactive gliosis. On 
MRI, ICMs present as mixed signal lesions of low and high intensity surrounded by a 
complete rim of T1 hypointensity. This “popcorn” appearance corresponds to the mixture of 
blood products at various stages of degradation within and around the lesion.
The prevalence of ICMs has been reported to be 0.4+0.6% in the general population; 
however, the incidence of ICMs after CRT remains largely unknown 6-9. A few studies have 
reported that ICMs occur within the field of prior radiation as early as five months, with the 
majority occurring 3+10 years after CRT 1, 4. The precise relationship between CRT dose 
and ICM development, however, is still unclear. Some studies have found a dose+dependent 
relationship noting decreased latency to ICM development in those who receive higher 
radiation doses 1, 5, 10. Others report an inverse relationship, finding that ICMs occur more 
commonly at the lower dose rim of the radiation field 5, 11. Regardless, it appears that low
+dose radiation is sufficient to induce ICMs, as children with leukemia, who are treated with 
relatively low doses of radiation (12+24 Gy), are also at increased risk for developing 
ICMs 11, 12.
There are conflicting reports as to whether radiation+induced ICMs differ pathologically 
from congenital/spontaneously occurring ICMs 1, 13-16. Clinically, radiation+ induced ICMs 
also appear to carry an increased risk of hemorrhage, reported at 3.9% per patient+year as 
compared to 0.25% in spontaneous ICMs 5, 7.
In this study, we assessed the incidence of radiographically detected ICMs in a single+center 
retrospective cohort of patients who received CRT during childhood. When available we 
reviewed pathology in order to further characterize the histologic features of radiation
+induced ICMs.
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We performed a retrospective cohort study of patients identified through the University of 
California, San Francisco (UCSF) Cancer Registry who received treatment at UCSF with 
CRT at age ≤ 18 years between 1980 and 2009. This cohort was previously described 17.
We identified 385 eligible patients whom we contacted through mail and invited to 
participate in the study. Twenty+three patients declined and were excluded from the study. 
Chart review was conducted for the remaining 362 patients, and of those, 104 (or surrogates 
when necessary) consented/assented to telephone interviews. Interviews were carried out 
with either the patient (if alive and ≥ 18 years of age at the time of the study; n=71), or the 
legal guardian of the patients currently < 18 years of age (n=20), or deceased (n=13). 
Information gathered during chart review and/or interview included baseline demographics 
(age, sex, race), primary cancer diagnosis and cancer treatment, age and date of diagnosis, 
radiation dose and treatment time, date of initial MRI to detect primary cancer diagnosis, 
and date of last MRI follow+up at our institution. Primary cancer diagnosis was based on 
pathology report, and date of surgery was confirmed by operative report. ICM identified by 
chart review was defined as physician documentation of ICM and/or brain imaging report 
that indicated ICM. Nine ICM patients were identified by chart review. ICM identified by 
interview was defined as participant report of a healthcare provider communicating the 
diagnosis to the patient. One ICM patient was identified on interview, and the patient's 
diagnosis was subsequently confirmed by chart and imaging review. For all patients with a 
diagnosis of ICM, all relevant brain imaging was obtained and reviewed by a study 
neuroradiologist (CH), who confirmed presence or absence of ICM, and specified anatomic 
locations for each ICM. For patients with ICM, additional information gathered by chart 
review included interval timing of imaging follow+up after CRT, and ICM related 
symptoms or treatment. Pathology specimens were obtained and reviewed in detail by a 
trained pathologist (JC) for all patients who underwent resection of the ICM. Data from 
medical records and imaging for all patients, including those who did not have ICMs, were 
collected through September 2011.
Statistical Analysis
Survival analysis was used to determine cumulative incidence of radiographically defined 
ICM after CRT. The primary outcome was time to radiographic appearance of ICM, 
calculated from last day of CRT to the date of first MRI with evidence of ICM. Censoring 
criteria were death, evidence of ICM or last follow+up MRI without evidence of ICM. For 
all patients with evidence of ICM, we confirmed that initial diagnostic imaging and follow
+up MRI after completion of CRT was negative for ICM until date of diagnosis. Most 
patients were followed with MRI scans at regular time intervals, every 1 to 2 years. To 
calculate incidence rates we used the midpoint of the interval between CRT/last normal MRI 
and first detection. For two patients who did not receive regular MRI follow+up, the median 
time between end of CRT and date of initial radiographic evidence of ICM was used as an 
estimate for our analysis. Because our primary goal was to estimate incidence and not to 
determine factors associated with time to occurrence of ICM, we did not account for the fact 
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that our data were interval censored, given that actual time of ICM development cannot be 
known. Rather, we used detection date to calculate incidence rates.
Results
Patient characteristics
Of the 362 eligible patients, we excluded 123 given that these patients had no MRI after 
completion of radiation therapy (Figure 1, supplemental Table 1). For the 239 patients, 
median age at time of CRT was 8.7 years (IQR, 4.6+13.0), and median age at last follow up 
was 15.1 years (IQR, 9.6+19.3). The majority of the patients were alive (n=165; 69%) at 
time of interview and/or chart review (Table 1, 2).
Radiographically detected ICM
In our cohort of 239 participants, we identified 10 patients with a diagnosis of ICM and all 
were confirmed radiographically. Figures 2 and 3 show representative MRI images of 
confirmed ICMs, revealing well+circumscribed lesions with heterogeneous T1 and T2 
signal, with surrounding hemosiderin and varying degrees of calcification and gliosis. Of the 
10 identified patients with ICMs, eight had had MRI follow+up every 1+2 years from the 
time of their CRT to their ICM diagnosis, while two patients were lost to follow+up after 
their initial CRT. These two patients underwent MRI more than 10 years after completion of 
CRT, at which time ICM was noted on imaging.
Baseline demographics of the patients with ICMs show that most were male (n=8; 80%). 
Nine out of 10 patients with ICMs received CRT doses >50 Gy (range 54+ 66 Gy) and one 
patient received low dose CRT of 24 Gy. Seven out of the 10 ICMs were located within the 
brain region that received high+dose CRT whereas the remaining three were located in the 
periphery of the radiation field (Table 2). Median age at CRT was 9.7 years (IQR= 
7.9+13.7) and median latency of ICM diagnosis (defined as time from CRT to midpoint 
between last cavmal+free MRI and cavmal diagnosis MRI) was 11.6 years post CRT (IQR= 
4.3+12.8) (Figure 4). Median latency decreases slightly to 9.0 if the two children with long 
intervals between last cavmal+free MRI and diagnosis MRI are excluded, but IQRs for this 
latency period remain largely unchanged ((3.9+12.6). The overall rate of radiographically 
detected ICM was 584 per 100,000 person years (95% CI 538+633). The cumulative 
incidence of radiographically detected ICM was 2% (95% CI 0.6+6%) at 5 years, 3% (95% 
CI 1+8%) at 10 years, and 14% (95% CI 7+26%) at 15 years.
Characteristics of ICM on Pathology
Of the 10 patients with radiographically detected ICMs, three patients underwent surgical 
resection for symptoms attributed to these lesions. Symptoms included new onset of 
headache plus seizures (patient 4), worsening headache (patient 5) and left+ sided 
numbness, left facial droop, left visual field defect, and decreased strength on the left side 
(patient 10). Two patients had resection specimens that were morphologically similar to 
spontaneously occurring or congenital ICMs. These specimens demonstrated thin+walled 
dilated loops of non+arterial vessels with little to no intervening brain tissue, and adjacent 
hemosiderin+laden macrophages. The third specimen exhibited characteristics of a 
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telangiectasia, with smaller, capillary+like vascular lumina separated by intervening brain 
parenchyma (Figure 3).
DISCUSSION
In this single+center retrospective cohort study, we found that children undergoing CRT for 
cancer therapy are at high risk for developing ICMs years after their initial therapy. 
Symptomatic radiation+induced+ICMs that are classified as such on imaging represent a 
spectrum of vascular disorders on histology ranging from capillary telangiectasia to a more 
classic ICM appearance. The cumulative incidence of ICMs after CRT has been estimated at 
3.9% and 5.0% within 10 and 15 years post CRT, respectively 3. In our cohort of pediatric 
cancer patients treated with CRT, the cumulative incidence of post+CRT ICM was found to 
be slightly higher at 3% at 10 years and 14% at 15 years however due to our small sample 
number the 95% CI are relatively large and that difference might not be statistically 
significant. Not all patients in our cohort, however, underwent imaging most sensitive to 
ICM detection, such as gradient echo imaging at high field strengths. Some ICMs may 
therefore have remained undetected, and our results likely underestimate the true incidence 
in this cohort.
Our study period spanned 29 years, and most cases of ICM were documented in the last 10 
years of the study, with the majority of ICMs documented in the last 5 years of the study. 
Although there is literature reporting radiographic identification of ICMs decades before the 
onset of our study period, the identified ICMs in the later years of our study could reflect the 
significant evolution in imaging technology, or even an increased awareness of ICM's 
among radiologists. Hence, these are additional factors that could have potentially 
contributed to underreporting of ICMs in the earlier years of the study.
Radiation+induced ICMs are known to develop over a long time period after CRT: in our 
cohort, 1 to 24 years after radiation. The median latency time to detection was 9 years; 
however, imaging was not done systematically at specific time points for all patients, so the 
exact latency could not be determined. Prior reports have estimated very similar latency 
times, ranging from 3 months to 22 years 11, 16, 18. These results suggest that pediatric 
cancer patients treated with CRT who present with new neurological findings should be also 
assessed for ICMs as a potential underlying diagnosis.
Young age at time of CRT has been associated with an increased risk of developing 
ICMs 1, 2, 5. Vinchon et al., however, reported that receiving CRT at an older age was a risk 
factor for developing ICMs 19. In our cohort, seven children were ≤ 12 years of age at time 
of CRT, while only three were treated with CRT at age >12 years. Although the rate of ICM 
detection per 100,000 person+years did not significantly differ between the <12 years age 
group (595, 95% CI 548+644, n=7) and the >12 years group (559, 95% CI 514+607, n=3), 
given the small sample size of the groups we cannot rule out the possibility that we lacked 
the power to detect a true difference.
Vascular malformations after CRT can exhibit heterogenous histopathology. A study by 
Baumgartner et al. found that radiation+induced ICMs are pathologically identical to 
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sporadic and familial ICMs 16. However, as Pozzatti et al. note, naturally occurring ICMs 
usually display elements that suggest a prolonged development, including calcification 20. In 
our study, two of the three pathological specimens showed classic appearance of ICMs and 
had no evidence of calcifications, whereas the other specimen was consistent with 
telangiectasia with evidence of calcifications. Although the pathogenesis of radiation
+induced ICMs is not well understood, it has been proposed that they result from radiation
+induced injury to the vasculature that histologically manifests as fibrinoid necrosis, 
hyalinization, and edema. Such changes can cause narrowing of the vascular lumen, leading 
to ischemia and the release of angiogenic factors, thus inducing dilation and proliferation of 
thin+walled vessels in adjacent areas 21. While ICM and capillary telangiectasia are 
considered separate, pathologically defined entities, they can have a similar imaging 
appearance, and some authors have proposed that they may be part of the same disease 
spectrum, representing early and late phases of radiation+induced vasculopathy, 
respectively 22. Although our sample size is small, our results are consistent with prior 
observations of pathological variation among radiographically detected ICMs.
Eight out of our 10 radiographically detected ICMs were found in male patients. This male 
predominance is supported by a review of the literature of radiation+induced ICMs and 
other small case series 4, 11. However, others have found no gender predilection in the 
development of ICMs after CRT 18. More studies with greater numbers are needed to assess 
whether a gender predilection is present in the risk of ICM development following CRT.
In our study, nine out of 10 patients with ICM had a CRT dose of >30 Gy, suggesting that 
higher CRT doses may confer an increased risk of developing ICM. Our results are 
supported by multiple prior studies reporting an association between CRT dose >30 Gy and 
increased ICM incidence 3, 4, 11. Similarly, our cohort reflects previously published data that 
most CRT+associated ICMs are asymptomatic 3, 12, as only three of our 10 radiographically 
detected ICMs required surgical intervention for symptom control.
It has been reported that risk of hemorrhage may be significant among pediatric patients 
with CRT+induced ICMs 11. However, no patients in our cohort presented with or 
subsequently developed a symptomatic hemorrhage during our follow up period. In one 
study, out of 419 patients who received CRT, 9 developed ICMs, and 3 of those developed 
symptomatic hemorrhagic ICMs requiring surgical intervention 11. By contrast, the rate of 
symptomatic hemorrhage in sporadically occurring ICMs in the general population is only 
2.4% per patient year 6. Studies showing a higher bleeding risk for CRT+induced ICMs had 
small cohorts of six to nine patients with ICMs; therefore larger, prospective studies are 
needed to further clarify this risk.
Conclusion
Radiation induced ICMs are frequent in patients who underwent CRT and occur on a 
histopathological spectrum.
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Flow diagram demonstrating the recruitment and participation of the 239 patients within the 
final study cohort.
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MRI appearance of vascular malformations: A: Example of classic MRI appearance of 
intracranial cavernous malformation (ICM) on T2+weighted imaging (Patient 3). Inferior 
left temporal lobe ICM showing complete low signal rim surrounding an area of mixed T2 
signal. B,C: Radiographic spectrum of vasculopathies in the same patient (Patient 9): B 
gadolinium+enhanced T1+weighted image showing a right periventricular ICM with small 
area of hyperintensity surrounded by a hypointense signal, and C: T2*+weighted image 
showing small and scattered radiation related microbleeds shown as areas of decreased 
signal intensity.
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MRI images of three patients who underwent surgical resection for symptomatic ICMs and 
the corresponding pathology. MRI images of radiographically identified ICMs are shown in 
A+C. A (Patient 4): T2*+weighted, B (Patient 5): T2 FLAIR, C (Patient 10): 
T1+weighted MRI. A and B depict the typical appearance of ICM (white arrow) on MRI 
with a core of mixed increased and decreased signal intensity surrounded by low signal 
intensity from adjacent hemosiderin+laden parenchyma. Corresponding pathology (a,b) 
showing classic ICM with abnormal thin walled, dilated non+arterial blood vessels (black 
thin arrows) with little to no intervening brain tissue surrounded by a rim of hemosiderin
+laden macrophages (black dashed arrows) in the adjacent parenchyma. C shows a right 
temporal+parietal ICM (white arrow) with high signal intensity and (c) corresponding 
pathology with dilated capillary+like vascular spaces (white dashed arrows) separated by 
intervening tissue.
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Overview of time to detection of ICM on MRI per individual patient. The figure depicts the 
latency time from the end of CRT to the time ICM was first detected on MRI. The symbol 
(o) denotes each patient's last MRI follow+up free of evidence of any lesion meeting 
radiographic criteria of ICM. Of note, imaging was not systematically acquired at specific 
time points therefore latency to radiographic detection of ICM is an estimate.
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Table 1
Patient characteristics of cohort
Characteristic Patients with ICM (n=10) Total cohort (n=229)
n (%) n (%)
Alive 7 (70) 158 (69)
Male gender 8 (80) 122 (53.3)
Race
    African-American 0 16 (7)
    Caucasian 8 (80) 122 (53.3)
    Asian American 0 27 (11.8)
    Latino 2 (20) 21 (9.2)
    Other/unknown 0 43 (18.8)
Age at cancer diagnosis, median (IQR) 8.6 (7.5,13.3) 8.4 (4.2,12.5)
Age at cranial radiation therapy, median (IQR) 9.7 (7.9,13.7) 8.7 (4.4,12.8)
Tumor type
    Medulloblastoma 2 (20) 33 (14.4)
    High-grade glioma 3 (30) 56 (24.5)
    Low-grade glioma 2 (20) 43 (18.8)
    Brainstem glioma 0 3 (1.3)
    Retinoblastoma 0 19 (8.3)
    ALL 0 1 (0.44)
    Others 3 (30) 74 (32.3)
ALL: acute lymphoblastic anemia; SD: standard deviation
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Table 2
Patient characteristics of those with radiographically detected ICM
Patient Gender Cancer Type Age at 
Radiation 
Therapy












1 male MB 6 6100 whole brain left frontal periventricular 1 1 7
2 female MB 7 6055 posterior fossa left parietal 1 6 13
3 female PA 7 5800 posterior fossa left inferior temporal 1 12 20
4* male PA 8 5580 right frontal right frontoparietal 1 19 28
5* male MG 8 5400 left temporal left temporal lobe 2 13 21
6 male AA 10 5940 whole brain bilateral thalami 1 6 16
7 male BL 11 2400 frontal frontal subcortical 0 14 26
8 male MEC 14 5760 parotid right frontal lobe 1 4 19
9 male PA 15 5580 whole brain right periventricular 0 24 39
10* male PA 16 6600 right temporal right temporal parietal 2 11 28
AA = Anaplastic astrocytoma, BL = Burkitt's lymphoma, PA = pilocytic astrocytoma, MB = medulloblastoma, MEC = mucoid epidermal 
carcinoma, MG = mixed germinoma
*
These patients received surgical resection for symptomatic ICM (Patient 4: seizures and headache; Patient 5: headache; Patient 10: L sided 
numbness, weakness and facial droop)
†presented as years after cranial radiation therapy.
J Child Neurol. Author manuscript; available in PMC 2016 June 01.
